Caribou Biosciences (CRBU) Tax Provisions (2020 - 2021)
Caribou Biosciences (CRBU) reported Tax Provisions of $321000.0 for Q4 2021, up 190.68% year-over-year from $110431.5 in Q4 2020, and up 190.68% quarter-over-quarter from -$354000.0 in Q4 2020.
Caribou Biosciences (CRBU) Tax Provisions (2020 - 2021) Analysis & Trends
Caribou Biosciences (CRBU) has 2 years of Tax Provisions data on file, last reported at $321000.0 in Q4 2021.
- Tax Provisions for Q4 2021 came in at $321000.0, up 190.68% year-over-year; the trailing twelve-month figure through Dec 2021 was $321000.0 (up 117.65% YoY), and the FY2025 annual result was -$550000.0, down 6011.11% from the prior year.
- Tax Provisions improved to $321000.0 in Q4 2021 per CRBU's latest filing, from -$354000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $321000.0 in Q4 2021 and troughed at -$1.2 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Caribou Biosciences | 156.73 Mn | 39.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 321,000.00 |
| Dec 31, 2020 | -354,000.00 |
| Sep 30, 2020 | -213,000.00 |
| Jun 30, 2020 | -50,000.00 |
| Mar 31, 2020 | -1.20 Mn |